Cerevel Therapeutics
CERE
$42.14
Share price
-0.01%
Change (1 day)
59.24%
Change (1 year)
Categories
Earnings for Cerevel Therapeutics (CERE)
Earnings in 2023 (TTM): -$0.44 B
According to Cerevel Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.44 B. In 2022 the company made an earning of -$0.36 B a decrease over its 2021 earnings that were of -$0.23 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cerevel Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.44 B | 23.05% |
| 2022 | -$0.36 B | 55.92% |
| 2021 | -$0.23 B | 48.08% |
| 2020 | -$0.16 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $4.94 B | -1,242.85% | 🇺🇸 USA |
 Campbell Soup CPB | $1.20 B | -378.72% | 🇺🇸 USA |
 Dow DOW | $0.65 B | -251.73% | 🇺🇸 USA |
 Dupont De Nemours DD | $0.50 B | -216.58% | 🇺🇸 USA |